论文部分内容阅读
目的观察氯吡格雷联合依达拉奉治疗进展性脑梗死的疗效和安全性。方法将98例进展性脑梗死患者随机分为两组各49例;对照组给予阿斯匹林治疗,研究组应用氯吡格雷联合依达拉奉治疗。两组在治疗前后根据临床疗效判定标准评分。结果治疗后研究组的总有效率(93.87%)明显高于对照组(79.59%)(P<0.05);神经功能缺损评分低于对照组(P<0.05),两组出血情况无差异。结论氯吡格雷联合依达拉奉治疗进展性脑梗死是一种安全有效的方法。
Objective To observe the efficacy and safety of clopidogrel plus edaravone in the treatment of progressive cerebral infarction. Methods A total of 98 patients with progressive cerebral infarction were randomly divided into two groups of 49 patients. The control group was given aspirin. The study group was treated with clopidogrel combined with edaravone. The two groups were scored according to the clinical efficacy criteria before and after treatment. Results After treatment, the total effective rate (93.87%) in the study group was significantly higher than that in the control group (79.59%) (P <0.05). The neurological deficit score was lower than that in the control group (P <0.05). Conclusion Clopidogrel combined with edaravone in the treatment of progressive cerebral infarction is a safe and effective method.